Clinical Trials Directory

Trials / Completed

CompletedNCT00274183

Nonalcoholic Fatty Liver Disease in Taiwanese Children

Prevalence, Clinicopathological Characteristics, Biomarkers and Genetics of Nonalcoholic Steatohepatitis in Taiwanese Children

Status
Completed
Phase
Study type
Observational
Enrollment
614 (actual)
Sponsor
Far Eastern Memorial Hospital · Academic / Other
Sex
All
Age
6 Years – 18 Years
Healthy volunteers
Not accepted

Summary

Nonalcoholic fatty liver disease (NAFLD) is an emerging and important disease in Taiwan. However, the prevalence and clinical characteristics have not been studied well. The purpose of this study is to resolve the aforementioned problem.

Detailed description

\[Study Subjects\] Obesity was defined as the BMI value \> 95 percentile by different age- and gender groups according to the standards of the Department of Health in Taiwan. \[Data Collection\] The following data were obtained for each subject: age, gender, BMI, waist and hip circumference. BMI was calculated as body weight (kg)/ height (m2). In fasting venous blood samples, we measured total serum bilirubin, alanine aminotransferase, aspartate aminotransferase, γ-glutamyltransferase, fasting glucose, triglyceride, total cholesterol,high-density lipoprotein cholesterol, insulin, glucose, and adiponectin. \[Liver Ultrasonography\] All participants underwent an ultrasonographic study of the liver performed by one operator. NAFLD was defined as the presence of an ultrasonographic pattern consistent with the following criteria: liver-kidney echo discrepancy, attenuated echo penetration and visibility of diaphragm, and obscure hepatic vessel structures.

Conditions

Timeline

Start date
2006-01-01
Primary completion
2018-12-01
Completion
2018-12-31
First posted
2006-01-10
Last updated
2019-04-09

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT00274183. Inclusion in this directory is not an endorsement.